PARP Inhibition--The New Frontier in Recurrent Ovarian Cancer: Highlights and Perspectives From Chicago Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, August 30, 2015

PARP Inhibition--The New Frontier in Recurrent Ovarian Cancer: Highlights and Perspectives From Chicago



 Note: discusses the different clinical trials (PARP drugs)

Medscape CME

Bradley J. Monk, MD; Thomas J. Herzog, MD
CME Released: 08/28/2015 ; Valid for credit through 08/28/2016

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.